Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
national
4
×
national blog main
national top stories
new york blog main
4
×
san francisco blog main
alnylam pharmaceuticals
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biomarin pharmaceutical
biotech
car-t
celgene
deals
hemophilia
pharmacy benefit managers
rna interference
sangamo therapeutics
sanofi
spark therapeutics
vc
What
gene
therapy
4
×
bio
roundup
aren’t
drug
moves
patients
science
advanced
alnylam’s
approval
becker
bff
billions
car
conference
cutting
deals
developers
devoted
disease
dollars
drugs
easl
eaton
edge
experiments
fda
form
healthcare
help
hot
imminent
impact
interference
kicked
launch
life
liver
Language
Current search:
national
×
therapy
×
" new york blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”